tiprankstipranks
Trending News
More News >
Proto Labs Inc. (PRLB)
NYSE:PRLB

Proto Labs (PRLB) AI Stock Analysis

Compare
947 Followers

Top Page

PR

Proto Labs

(NYSE:PRLB)

Rating:73Outperform
Price Target:
$42.00
▲(9.55%Upside)
Proto Labs exhibits strong financial fundamentals and positive corporate changes, but faces challenges with profitability and valuation. The positive earnings call and new CEO appointment offer potential for future growth. However, overvaluation concerns and macroeconomic headwinds remain significant risks.
Positive Factors
Financial Performance
Proto Labs reported better-than-expected financial results for their 1Q25, including revenues of $126.2 million.
Industry Position
The positive impact from recent consolidation in the additive manufacturing industry has reduced the number of competitors, benefiting ProtoLabs.
Strategic Initiatives
Proto Labs announced a new $100 million share repurchase program and a plan to increase marketing efforts for its production capacities.
Negative Factors
Earnings Forecast
Valuation expansion will be restrained in the near term given the forecast for an earnings decline in 2025, attributable to higher expenses and the ongoing mix shift to lower-margin network sales.
Revenue Segments
Revenue declines were noted in Injection Molding and 3D Printing segments, despite overall positive results.

Proto Labs (PRLB) vs. SPDR S&P 500 ETF (SPY)

Proto Labs Business Overview & Revenue Model

Company DescriptionProto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end markets. The company was incorporated in 1999 and is headquartered in Maple Plain, Minnesota.
How the Company Makes MoneyProto Labs makes money primarily through its digital manufacturing services, which include 3D printing, CNC machining, injection molding, and sheet metal fabrication. The company generates revenue by providing these services to a wide range of industries on a project-by-project basis, allowing clients to order custom parts with fast turnaround times. Proto Labs leverages its proprietary software to automate the quoting and manufacturing process, enabling cost-effective production and scalability. Key revenue streams include the fees charged for manufacturing services and any additional costs associated with materials and expedited shipping. Partnerships with leading technology firms and a robust customer base further contribute to the company's earnings by ensuring a steady demand for its on-demand manufacturing solutions.

Proto Labs Key Performance Indicators (KPIs)

Any
Any
Developers and Engineers Served
Developers and Engineers Served
Measures the number of developers and engineers using Proto Labs' services, indicating the company's reach and influence within the manufacturing and prototyping sectors, as well as potential for future growth.
Chart InsightsProto Labs has seen fluctuations in the number of developers and engineers served, with a notable dip during the pandemic in 2020 and a subsequent recovery. However, recent quarters show a slight decline, aligning with macroeconomic headwinds and challenges in segments like Injection Molding and 3D Printing. Despite these challenges, the company is focusing on expanding production use cases and reinforcing its core prototyping business, which may stabilize or increase engagement in the future. Strategic investments in marketing and production capabilities are expected to drive further customer engagement.
Data provided by:Main Street Data

Proto Labs Earnings Call Summary

Earnings Call Date:May 02, 2025
(Q1-2025)
|
% Change Since: 7.09%|
Next Earnings Date:Aug 01, 2025
Earnings Call Sentiment Positive
The earnings call reflects a generally positive outlook with strong revenue performance, growth in production offerings, and robust cash flow. However, year-over-year revenue declines and challenges in certain segments like Injection Molding and 3D Printing highlight ongoing challenges. The company's adaptability and strategic focus on production are evident positives, but macroeconomic uncertainties and tariff-related challenges remain concerns.
Q1-2025 Updates
Positive Updates
Strong Revenue Performance
Proto Labs reported first quarter revenue of $126 million, near the upper end of their guidance range with earnings per share of $0.33, also near the top of expectations.
Growth in Production Offerings
Customers utilizing Proto Labs' combined offer grew more than 45% over the trailing 12 months, with revenue per customer increasing by 3% year-over-year. Production revenue exceeded expectations in the first quarter.
Expansion in Aerospace and Defense
Proto Labs' revenue from aerospace and defense customers has increased significantly, with partnerships including Blue Origin, NASA, and Lockheed Martin.
Improved Gross Margin
First quarter consolidated non-GAAP gross margin increased 140 basis points sequentially to 44.8%.
Positive Cash Flow and Shareholder Returns
Generated $18.4 million in cash from operations during the first quarter and returned $20.9 million to shareholders through repurchases, exceeding 122% of free cash flow.
Negative Updates
Year-Over-Year Revenue Decline
First quarter revenue was down 1% year-over-year in constant currencies, partly due to macroeconomic headwinds and manufacturing contraction.
Decline in Injection Molding and 3D Printing
Injection Molding revenue declined 7% year-over-year, and 3D Printing revenue was down 6% due to lower order trends in late 2024 and early 2025.
Challenges with Tariffs
Uncertainty regarding tariffs could impact pricing, although Proto Labs has not yet seen substantial cost increases from tariffs.
Company Guidance
During the Proto Labs First Quarter 2025 Earnings Call, Rob Bodor, President and CEO, highlighted the company's strong start to the year with revenue of $126 million, which was near the upper end of their guidance range, and earnings per share of $0.33. The company experienced a sequential gross margin expansion and a strong free cash flow, with free cash flow representing 14% of revenue. Despite a slight year-over-year decline in revenue due to macroeconomic headwinds, Proto Labs reported a 4% sequential increase, driven by a 45% growth in customers utilizing their combined offerings and a 3% increase in revenue per customer. The company's strategic investment in marketing and its production capabilities have resulted in increased customer engagement and production revenue that exceeded expectations in the first quarter. For the second quarter of 2025, Proto Labs expects revenue between $124 million and $132 million, with a focus on expanding production use cases and reinforcing its core prototyping business.

Proto Labs Financial Statement Overview

Summary
Proto Labs exhibits a solid financial foundation with stable income statement performance, a strong balance sheet, and efficient cash flow management. While profitability margins are under pressure, the company's low leverage and strong cash flow generation provide resilience against market fluctuations. Continued focus on improving net profitability could enhance overall financial health.
Income Statement
75
Positive
Proto Labs shows a stable gross profit margin at approximately 44% in TTM, indicating solid cost management. However, the net profit margin is relatively low at around 3%, reflecting pressure on profitability potentially due to higher operating expenses. Revenue growth has been stagnant, with a slight decline in TTM compared to the previous annual period.
Balance Sheet
80
Positive
The company maintains a strong balance sheet with a low debt-to-equity ratio, indicating conservative leverage use. The equity ratio is robust at nearly 100%, showcasing financial stability. However, return on equity is modest at around 2%, suggesting potential inefficiencies in generating shareholder returns.
Cash Flow
85
Very Positive
Proto Labs demonstrates strong cash flow management, with a healthy free cash flow that grew 11.6% from the previous period. The operating cash flow to net income ratio is high, indicating efficient cash generation relative to reported earnings. This strong cash position supports operational flexibility.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
499.20M500.89M503.88M488.40M488.10M434.39M
Gross Profit
221.43M223.20M221.99M215.47M222.69M217.83M
EBIT
17.61M19.91M28.17M151.88M40.34M59.84M
EBITDA
46.82M60.68M66.58M66.37M80.83M92.43M
Net Income Common Stockholders
14.92M16.59M17.22M-103.46M33.37M50.87M
Balance SheetCash, Cash Equivalents and Short-Term Investments
109.68M103.09M102.80M80.13M77.51M161.69M
Total Assets
769.80M743.51M772.35M802.17M928.58M744.20M
Total Debt
4.96M3.52M5.48M21.35M7.44M13.33M
Net Debt
-87.85M-85.56M-78.31M-35.20M-58.48M-114.27M
Total Liabilities
82.49M73.36M77.06M104.52M100.09M99.85M
Stockholders Equity
687.31M670.15M695.29M697.65M828.49M644.36M
Cash FlowFree Cash Flow
76.63M68.66M45.16M40.39M21.03M59.96M
Operating Cash Flow
74.87M77.83M73.27M62.08M55.24M106.97M
Investing Cash Flow
-20.91M-13.58M-4.55M-43.09M-94.66M-95.47M
Financing Cash Flow
-63.86M-58.55M-41.86M-27.92M-22.20M-10.73M

Proto Labs Technical Analysis

Technical Analysis Sentiment
Positive
Last Price38.34
Price Trends
50DMA
36.65
Positive
100DMA
38.23
Positive
200DMA
36.23
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
52.19
Neutral
STOCH
66.48
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PRLB, the sentiment is Positive. The current price of 38.34 is below the 20-day moving average (MA) of 38.99, above the 50-day MA of 36.65, and above the 200-day MA of 36.23, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 52.19 is Neutral, neither overbought nor oversold. The STOCH value of 66.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PRLB.

Proto Labs Risk Analysis

Proto Labs disclosed 35 risk factors in its most recent earnings report. Proto Labs reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Proto Labs Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$696.88M31.136.61%0.33%-0.33%-7.06%
73
Outperform
$911.37M64.222.22%-1.32%-21.84%
MEMEC
70
Outperform
$306.92M13.899.40%-8.42%164.82%
67
Neutral
$390.97M12.099.13%8.06%38.46%
66
Neutral
$4.51B12.295.40%248.53%4.14%-12.41%
RYRYI
59
Neutral
$704.77M37.86-0.78%3.43%-9.04%-108.47%
59
Neutral
$1.42B8.26%2.38%-5.74%-192.12%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PRLB
Proto Labs
39.20
7.33
23.00%
IIIN
Insteel Industries
35.90
6.53
22.23%
NWPX
Northwest Pipe Company
39.58
5.91
17.55%
RYI
Ryerson Holdings
21.89
0.65
3.06%
MEC
Mayville Engineering Company
14.91
-1.96
-11.62%
CMPO
CompoSecure
13.92
8.72
167.69%

Proto Labs Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Proto Labs Extends Consulting Agreement with Former CEO
Neutral
May 30, 2025

On May 20, 2025, Robert Bodor stepped down as President and CEO of Proto Labs, Inc., and subsequently entered into a consulting agreement with the company to assist in management transition. The agreement, which includes a monthly fee and provisions for stock options, was extended on May 28, 2025, to continue through November 11, 2025, allowing Dr. Bodor to provide transitional consulting services.

The most recent analyst rating on (PRLB) stock is a Buy with a $44.00 price target. To see the full list of analyst forecasts on Proto Labs stock, see the PRLB Stock Forecast page.

Executive/Board ChangesBusiness Operations and StrategyFinancial Disclosures
Proto Labs Appoints Suresh Krishna as New CEO
Positive
May 21, 2025

On May 21, 2025, Proto Labs announced the appointment of Suresh Krishna as the new President and CEO, effective May 20, 2025, succeeding Robert Bodor. With a strong background in driving growth and innovation, Krishna is expected to enhance Proto Labs’ market position and accelerate its production expansion initiatives. The company also reaffirmed its second-quarter 2025 financial outlook, projecting revenue between $124 million and $132 million, and highlighted its ongoing commitment to customer-centric innovation and operational excellence.

The most recent analyst rating on (PRLB) stock is a Buy with a $44.00 price target. To see the full list of analyst forecasts on Proto Labs stock, see the PRLB Stock Forecast page.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.